1. The strategic cooperation between pharmaceutical network and Bayer pharmaceutical has been upgraded to explore and innovate the digital patient service model

Yiouda health news on August 4. Recently, the internet pharmaceutical health enterprise 1 pharmaceutical network has reached in-depth strategic cooperation with Bayer pharmaceutical, a world-famous pharmaceutical enterprise. The two sides will carry out in-depth cooperation in various fields such as omni-channel drug commercialization, chronic disease management, patient education and Internet hospitals to explore the innovative service mode of digital "medicine + medicine". 1. By integrating technologies such as intelligent supply chain, big data and cloud services, pharmaceutical network will help Bayer pharmaceutical's rich innovation and high-quality original drugs and other products expand and penetrate into a broader online and offline market in a more efficient way. At the same time, relying on the Internet hospital, the two sides will also explore and jointly build a disease management platform to create a digital "medical + drug" service model for patients, including doctor-patient communication, course management and online and offline DTP delivery. It is worth noting that according to the strategic cooperation agreement, 1 pharmaceutical network has also become the only digital medical health platform for Bayer pharmaceutical to realize direct supply cooperation in China. It is reported that Bayer pharmaceutical and 1 pharmaceutical network have previously established a multi-level cooperative relationship in drug service, patient management, digital marketing and so on. After this strategic cooperation upgrade, the two sides will further integrate their respective expertise, continue to deepen cooperation from the aspects of chronic disease professional management, retail channel management and patient education, and jointly build a patient-centered health service system.